Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WX-554 in Advanced Solid Tumours
NCT01581060Phase 2Terminated
- Sponsor
- Heidelberg Pharma AG
- Start
- Mar 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WX-554 in solid tumor, sponsored by Heidelberg Pharma AG. Started Mar 2012; status: terminated.
02
Drugs
WX-554
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01581060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581060.